Selected Media Contributions and Appearances
Focus On: Daniela Drago, Regulatory Focus, May 2018.
Students Learn from the Experts at GW’s International Regulatory Science Institute, SMHS Magazine, Issue 51, November 2016.
Ten Can’t Miss Regulatory Convergence Sessions: 1-5, , August 2016.
George Washington University Offers Regulatory Affairs Graduate Program – Program director stresses importance of a global focus for regulatory affairs professionals, Medical Products Outsourcing, January 2014.
Articles in Peer-reviewed Journals
Felix T., Jordan B. J., Akers C., Patel B., Drago D. Current state of biologic pharmacovigilance in the European Union: improvements are needed. Expert Opinion on Drug Safety, 2019, 18(3): 231-240.
Purnama A., Drago D., FDA regulatory pathways for medical devices. Regulatory Rapporteur, 2019, 16 (5) (Suppl): pp. i-iv.
Drago D., Three common misconceptions about the FDA. Journal of the American Academy of PAs, 2019, 32 (2): pp. 10–11.
Georgopoulos L., Drago D., Paediatric medicines: Creating an integrated EU/US product development strategy. Regulatory Rapporteur, 2018, 15 (12) (Suppl): pp. i-iv.
Jordan C., Drago D., Bringing new drugs to the market in the US: an overview. Regulatory Rapporteur, 2018, 15 (11) (Suppl): pp. i-iv.
Drago D., McDonald P., Lotrecchiano G, Communicating Transdisciplinary Characteristics in Regulatory Affairs: An Example in Health Professions Education. Informing Science Institute’s International Journal of the Emerging Transdiscipline, 2018, 21, pp. 219-234.
Harwood K., McDonald P., Butler J., Drago D., Schlump K., Comparing student outcomes in traditional vs. intensive online graduate programs in health professional education. BMC medical education, 2018, 18(1), pp. 240-249.
McDonald P., Butler J., Schlump K., Harwood K., Drago D. Design for Success: Identifying a Process for Transitioning to an Intensive Course Delivery Model in Health Professions Education. Medical Education Online, 2018, 23, 1415617, pp. 1-10.
Drago D., Alsbury S., Connolly T. Promoting Excellence in the Regulatory Affairs Profession: A Competency Framework. Regulatory Rapporteur, 2017, 14, 10, pp. 16-19.
Drago D., Singer N. 483 Response: Common Pitfalls and How to Avoid Them. European cells & materials 32, S1, 2016, p. 15.
Drago D., Yap M., Ekmekci O. Increasing the Odds of Effective Drug Development: Elevating Regulatory Affairs Professionals to Strategic Partners, Clinical Research and Regulatory Affairs, 2016, 33, pp. 59-65
Drago D., Shire S., Ekmekci O. Improving Regulatory Education: Can We Reconcile Employers’ Expectations With Academic Offerings?, Therapeutic Innovation & Regulatory Science, 2015, 50, pp. 330-336.
Drago D., Pregosin P.S.; Pfaltz A. Selective anion effects in chiral complexes of iridium via diffusion and HOESY data: relevance to catalysis, Chemical Communications, 2002, 3, pp. 286-287.
Drago D., Pregosin P.S. Palladium-Duphos structural and enantioselective hydroarylation chemistry, Organometallics, 2002, 21, pp. 1208-1215.
Geldbach T.J., Drago D., Pregosin P.S. A weak η1 π-bonding mode for Ru arene complexes. Nitrile, isonitrile and phosphine derivatives of Ru phosphino arene chelating complexes, Journal of Organometallic Chemistry, 2002, 643, pp. 214-222.
denReijer C.J., Drago D., Pregosin P.S. Ruthenium (II)-MeO-Biphep-Arene Dications: Acetylene Reactions and Unexpected Cyclometalation, Organometallics, 2001, 20, pp. 2982-2989.
Drago D., Pregosin P.S. Allyl, olefin, aryl and alkyl organometallic palladium complexes of 1, 2-bis [(2R, 5R)-2, 5-dimethylphospholanyl] benzene, Journal of the Chemical Society, Dalton Transactions, 2000, 18, pp. 3191-3196.
Geldbach T.J., Drago D., Pregosin P.S. Alcohol induced stereospecific P–C bond cleavage to afford Ru–phenyl derivatives containing three different types of stereogenicity: novel and unprecedented complexes of P(OH)(OR)Ph, Chemical Communications, 2000, 17, pp. 1629-1630.
Drago D., Pregosin P.S., Razavi A. 13C NMR Studies on Zr (ansa-Fluorenyl) Complexes. Molecules with Flexible Bonding Modes, A. Organometallics, 2000, 9, pp. 1802-1805.
Drago D., Pregosin P.S., Tschoerner M., Albinati A. Structural distortions in Pd–MeO-Biphep and Pd–Binap aryl complexes. Anomalies induced via electronic effects”, Journal of the Chemical Society, Dalton Transactions, 1999, 14, pp. 2279-2280.
Arena C.G., Drago D., Panzalorto M., Bruno G., Faraone F. Diphosphinito-bridged ruthenium(II) and rhodium(III) complexes with stereogenic metal centers, Inorganica Chimica Acta, 1999, 292, pp. 84-95.
Arena C.G., Drago D., Faraone F. Hydroformylation of styrene and 1-octene catalyzed by binuclear and oligomer rhodium(I) complexes containing the bis-p-phosphinito ligands [(p-Ph2POC6H4)2X] (X=O, CMe2, S), Journal of Molecular Catalysis A: Chemical, 1999, 144, pp. 379-388.
Drago D., Pacifici E., Bain S., “Drugs.” An Overview of FDA Regulated Products. Academic Press, 2018. 45-83.
Georgopoulos L., Drago D., “Global Pediatric Drug Development.” Fundamentals of International Regulatory Affairs. RAPS, 2018. 417-436.
Articles in Trade Journals
Drago D., Singer N. Effective Writing Sets You Apart in the Health Care Field: A How-To Guide, AFDO Journal, March 2017, pp. 1-4.
Shire S., Swanson C., Drago D., Feagin J. “Core Competencies Provide a Roadmap for Strengthening Regulatory Education”, Regulatory Focus, September 2014, pp. 1-8.
Singer N., Drago D. Getting Cooperation for Regulatory Compliance, Sparta Systems, June 2014, pp. 1-3.
Drago D., Shire S., Swanson C., Feagin J. “Answering the Call for Excellence in Regulatory Education”, Regulatory Focus, May 2014, pp. 1-4.
Drago D., “Should I consider a career in Regulatory Affairs?” Medical Device and Diagnostic Industry (MD+DI), August 2013, pp. 1-3BringingFDA